A recent appellate court decision coupled with a spate of warning letters sets the stage for more class action lawsuits like the proposed ones filed against CBD companies this week, experts say.
Publicly held CBD companies have now been in business long enough to report comparative financial results which back up the common perception that sales in the sector continue to boom.
Hemp-derived CBD brands Charlotte’s Web and Infinite Product Co. have both been hit with proposed class action lawsuits filed in California that allege they misled consumers by marketing their products as dietary supplements when FDA has specifically...
While penning 15 warning letters about CBD in one day (more than the FDA has sent in three years) attracted a lot of media attention, does it signal a change in enforcement priorities for the agency, which has repeatedly warned that cannabidiol is not...
Sparked by proposed US Department of Agriculture regulations that would drastically alter the certification process for industrial hemp, two lawmakers from Oregon want the agency to make several changes before it finalizes rules for the US Domestic Hemp...
The US Food and Drug Administration has stated that it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS) for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”.
Defendants in a recent spate of lawsuits alleging discrepancies between the amount of CBD advertised on pack and the amount contained in the products, have hit back in motions to dismiss, with one arguing that such cases should be stayed until the FDA...
Pressure continues to build to find a resolution to the CBD impasse. A trade organization and a state government have filed notices with FDA on the issue.
CBD has caught the public's imagination as an ingredient offering a host of potential health benefits. But for all the hype, CBD also courts controversy. To move from a trending ingredient to an ingredient trend, the sector will need to address some...
The Journal of Dietary Supplements is planning a special issue devoted to the toxicology, pharmacology, and potential regulatory pathways for CBD and other cannabinoids, and is inviting submissions.
